Pre-Investigational New Drug (IND) Meeting
A pre-investigational new drug meeting, usually shortened to IND, is a meeting that takes place between those sponsoring a new drug and representatives of the FDA. This is an opportunity for individuals to get some feedback on their application from FDA officials before they formally submit an application. If drug sponsors are able to get information from the FDA before they file a formal application, they may use the feedback to tweak their application, increasing the chances of the application being approved. FDA officials will take a look at the results of the research study, compare them to drugs that are currently used to treat certain illnesses and conditions, and use that information to point research sponsors in the right direction.